{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T10:55:36Z","timestamp":1725792936011},"reference-count":20,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>The present study was undertaken to estimate the approximate size of nuclear regions occupied by nucleolar bodies during the cell differentiation and maturation. The differentiation and maturation of human leukemic granulocytic cells in patients suffering from the chronic phase of the chronic granulocytic leukemia (CML) represented a convenient model for such study because of the large number of cells for the diameter measurements at the single cell level. Early and advanced differentiation or maturation stages of these cells are well defined and nucleolar bodies and nuclear outlines are easily seen by simple cytochemical methods for the visualization of RNA and silver stained proteins in smear preparations. During the cell differentiation and maturation, the estimated size of the nuclear region occupied by nucleolar bodies decreased in both untreated and treated patients with the anti-leukemic therapy. However, the size reduction of nucleolar bodies in differentiated and mature cells was larger than that of the nucleus. In addition, the results also indicated that the nuclear region occupied by nucleolar bodies was characteristic for each differentiation and maturation stage of the granulocytic cell lineage and was not substantially influenced by the anti-leukemic therapy of CML patients.<\/jats:p>","DOI":"10.33549\/physiolres.934045","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T13:39:25Z","timestamp":1566913165000},"page":"633-638","source":"Crossref","is-referenced-by-count":4,"title":["To the approximate size of the nuclear region occupied by nucleolar bodies during cell differentiation and maturation using the human leukemic granulocytic lineage as a convenient model"],"prefix":"10.33549","author":[{"given":"K.","family":"Smetana","sequence":"first","affiliation":[{"name":"Institute of Hematology and Blood Transfusion, Prague, Czech Republic. karel.smetana@uhkt.cz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Klamov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mikulenkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"ref0","unstructured":"ASTALDI G, LISIEWICZ J: Lymphocytes, Structure, Production, Functions. Idelson (ed.), Naples, 1971."},{"key":"ref1","unstructured":"ATCC (American Type Culture Collection): K 562, Kasumi 1, HL 60. Search Catalog Internet, 2017."},{"key":"ref2","unstructured":"BUSCH H, SMETANA K: The nucleolus. Academic Press, New York, 1970."},{"key":"ref3","unstructured":"CLINE MJ: The white cell. Harward University Press, Cambridge, 1975. Foot NC: The identification of tumor cells in sediments of serous effusions. Am J Pathol 13: 1-14, 1937."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"GRASSO JA, WOODART JV, SWIFT H: Cytochemical studies of nucleic acids and proteins in erythrocytic development. Proc Natl Acad Sci US 50: 134-140, 1963.","DOI":"10.1073\/pnas.50.1.134"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"HOM\u00c1\u010cEK M, KOV\u00c1\u010cIK I, MAZEL T, CMARKO D, B\u00c1RTOV\u00c1 E, RA\u0160KA I, SMIRNOV V: Fluctuations of PO I and fibrillarin contents of the nucleoli. Nucleus 8: 421-423, 2017.","DOI":"10.1080\/19491034.2017.1306160"},{"key":"ref6","unstructured":"MCGREW E: Criteria for the recognition of malignant cells in circulating blood. Acta Cytol 9: 58-60, 1965."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"OCHS RL: Methods used to study structure and function of the nucleolus. Methods Cell Biol. 53: 303-321, 1998.","DOI":"10.1016\/S0091-679X(08)60884-5"},{"key":"ref8","unstructured":"POLITI EN, LAZARIS AC, KAVANTZAS A, KOUNSELINI H: Comparison between morphometry and immunostaining of malignant cells in non-small cell lung cancer. Anal Quant Cytol Histol 25: 169-176, 2003."},{"key":"ref9","unstructured":"RUNDLES RW: Chronic myelogenous leukemia. In: Hematology. WJ WILLIAMS, E BEUTLER, AJ ERSLEV, MA LICHTMAN (eds), McGraw-Hill, New York, 1983, pp 196-213."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"SMETANA K, JIR\u00c1SKOV\u00c1 I, PERLAKY L, BUSCH H: The silver reaction of nucleolar proteins in the main structural compartments of ring-shaped nucleoli in smear preparations. Acta histochem 101: 167-183, 1999","DOI":"10.1016\/s0065-1281(99)80016-6"},{"key":"ref11","unstructured":"SMETANA K, KARBAN J, TRN\u011aN\u00dd M: To the nucleolar and nuclear size in lymphocytes of patients with B chronic lymphocytic leukemi. (In Czech) In: XXXII. Olomouck\u00e9 hematologick\u00e9 dni 2017, p 43."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"SMETANA K, KLAMOV\u00c1 H, JIR\u00c1SKOV\u00c1 I, MIKULENKOV\u00c1 D: Perinucleolar heterochromatin during the cell differentiation using human leukemic neutrophils as a convenient model. J Appl Biomed 13: 225-232, 2015.","DOI":"10.1016\/j.jab.2015.03.001"},{"key":"ref13","unstructured":"SMETANA K, LEJNAR J, POTM\u011a\u0160IL M: A further contribution to the demonstration of RNA and nucleoli in smear preparations. Folia Haematol 91: 381-384, 1969."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"SMETANA K, LIKOVSK\u00dd Z: Nucleolar silver-stained granules in maturing erythroid and granulocytic cell, Cell Tissue Res 237: 337-367, 1984.","DOI":"10.1007\/bf00217159"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"SMETANA K, OTEV\u0158ELOV\u00c1 P, KU\u017dELOV\u00c1 M, Z\u00c1POTOCK\u00dd M: To the nuclear region occupied by nucleolar bodies in human leukemic myeloblasts of Kasumi 1 and K 562 lineages. Folia Biol (Praha) 64: 182-185, 2018.","DOI":"10.14712\/fb2018064050182"},{"key":"ref16","unstructured":"SMETANA K, PILCOV\u00c1 H, PLUSKALOV\u00c1 Z, HRKAL Z: A karyometric study on ageing and butyrate or imatinib treated human leukemic myeloblasts represented by K562 cells originated from chronic myeloid leukemia. Neoplasma 54: 359-364, 1977."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"STEPINSKI D: The nucleolus, an ally, and an enemy of cancer cells. Histochem Cell Biol 150: 607-629, 2018.","DOI":"10.1007\/s00418-018-1706-5"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"TOCCO VJ, CHRITOPHER KG, MATTHEWS JH., AGGARVAL V, PASCHALL, L., LUESCH H, LICHT JG, DICKINSON RB, LELE TP: The nucleus is irreversibly shaped by motion of cell boundaries in cancer and non-cancer cells. J Cell Physiol 233: 1446-1454, 2018.","DOI":"10.1002\/jcp.26031"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"TONE K, KOJIMA K, HOSHIAI K, KUMAGAI N, KIJIMA H, KUROSE A: An ancillary method in urine cytology: Nucleolar\/nuclear volume ratio for discrimination between benign and malignant urothelial cells. Diagn Cytopathol 44: 483-491, 2016.","DOI":"10.1002\/dc.23469"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T16:27:56Z","timestamp":1721665676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2019\/68_633.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934045","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}